euro adhoc: november AG / other / IBL reaches agreement Subsidiary of november AG goes to Meddens Diagnostic BV (E)

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

28.07.2008

IBL Gesellschaft für Immunchemie und Immunbiologie mbH, a 100% subsidiary of
november AG, Erlangen, is sold to Meddens Diagnistics BV, Amsterdam in an asset
deal transaction. IBL had filed for insolvency last year.
The transaction is to be concluded in the next month.

Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

end of announcement euro adhoc
--------------------------------------------------------------------------------

emitter: november AG
Ulrich-Schalk-Str. 3
D-91056 Erlangen
phone: +49(0)9131-75088-0
FAX: +49(0)9131-75088-99
mail: info@november.de
WWW: http://www.november.de
sector: Biotechnology
ISIN: DE000A0S9N72
indexes: CDAX, Prime All Share, Technologie All Share
stockmarkets: regulated dealing/prime standard: Börse Frankfurt, free trade:
Börse Berlin, Börse Stuttgart, Börse Düsseldorf, Börse Hannover,
Börse München
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | OTB

print